Product Information
LABETALOL HCL 200 MG TABLET is a generic product labeled by Innogenix, Inc., priced at $0.1435 per EA under NDC 71247012701. Its NADAC has been published 244 times since Jun 23, 2021.
FDA first approved this application on Jul 29, 1999. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Innogenix, Inc.NDC
71247012701
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
LABETALOL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075215FDA Approved
7/29/1999
TE Code
AB
On Market Since
2/8/2021
Pharmacological Classes
Price Statistics
The NADAC for LABETALOL HCL 200 MG TABLET has been published 244 times since Jun 23, 2021, and over the history we have for it it has declined 28.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1435 per EA |
|---|---|
| All-time high | $0.2060 (Sep 15, 2021) |
| All-time low | $0.1222 (Nov 20, 2024) |
| 52-week high | $0.1481 |
| 52-week low | $0.1423 |
| Median price | $0.1626 |
| Average price | $0.1621 |
| Largest weekly change | -25.6% (Apr 17, 2024) |
| Weeks tracked | 244 |
| Tracking since | Jun 23, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-3.1%
3Y
-12.1%
5Y
-30.3%
All
-28.7%
Last surveyed Feb 18, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LABETALOL HCL 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LABETALOL HCL 200 MG TABLET, manufactured by Innogenix, Inc., is $0.1435 per EA (NDC 71247012701), effective Feb 18, 2026.
How has the price of LABETALOL HCL 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for LABETALOL HCL 200 MG TABLET has declined 28.7%. It has been tracked across 244 weekly CMS publications since Jun 23, 2021.
What are the highest and lowest recorded NADAC prices for LABETALOL HCL 200 MG TABLET?
Since Jun 23, 2021, the NADAC for LABETALOL HCL 200 MG TABLET has ranged from a low of $0.1222 (Nov 20, 2024) to a high of $0.2060 (Sep 15, 2021), with a median of $0.1626 per EA.
Are there cheaper alternatives to LABETALOL HCL 200 MG TABLET?
Yes. 12 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LABETALOL HCL 200 MG TABLET, is $0.1421 per EA — about 1% below LABETALOL HCL 200 MG TABLET.
Who manufactures LABETALOL HCL 200 MG TABLET?
LABETALOL HCL 200 MG TABLET (NDC 71247012701) is labeled by Innogenix, Inc., and CMS classifies it as a generic product.